Home Torus Biosystems

Torus Biosystems

In operation
Series A
Molecular Diagnostics Technology Developer
Basic
Enterprise Profile

Basic Information

Torus Biosystems is developing next-generation POC molecular diagnostic technology for syndromic infectious diseases, which can detect and quantify DNA within 30 minutes. The Synestia™ system employs an integrated testing approach, offering faster and more accurate results than traditional methods. Its mission is to transform patients' lives by providing breakthrough innovations in infectious disease diagnostics.
Torus Biosystems, Inc.
Cambridge,Massachusetts,United States of America
less than 15 people
January 01, 2019
info@torus.bio

Enterprise Profile

Industrial Sector
Medical Device R&D and Design
Technology
POCT Molecular Diagnostics Genetic Testing
Concept
Infectious Diseases Department Disease Diagnosis Department of Clinical Laboratory
Application Scenarios
Medical Device Consumables Early Disease Screening Companion Diagnostics